A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients
Authors:
- 13 June 2014
- journal article
- clinical trial
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 39 (5) , 521-526
Abstract
What is known and objective In China, lidocaine together with 2 mg/mL of pingyangmycin (PYM, also known as bleomycin A5) is recommended for the treatment of venous malformations (VMs). The purpose of this study was to investigate whether lidocaine has a synergistic effect with PYM in improving the therapeutic outcomes of patients with VMs. Additionally, this study aimed to evaluate the outcomes of sclerotherapy for VMs using an intralesional injection of a low concentration of PYM (0·5 mg/mL). Methods A total of 281 patients with VMs were treated with 0·5 or 2 mg/mL of PYM with or without lidocaine and dexamethasone (DEX). All of the patients received a direct intralesional injection at a rate of 1 mL/min, and the volume of the solution varied from 1·5 to 6·0 mL per injection. Results and discussion No significant differences were observed in the clinical outcomes between the PYM and PYM + lidocaine treatment groups (P > 0·05). The clinical outcomes were similar between the groups that were treated with 0·5 and 2 mg/mL of PYM, but the swelling and pain in the patients who were treated with 0·5 mg/mL of PYM were less severe compared with the patients who were treated with 2 mg/mL of PYM. A total of 29 patients with VM lesions on the glans penis were treated with 0·5 mg/mL of PYM + 0·5% lidocaine. Of these patients, 26 were cured, whereas three experienced a marked improvement. What is new and conclusion Lidocaine does not have a synergistic effect with PYM in improving the therapeutic outcomes of patients with VMs. Sclerotherapy with a low concentration of PYM (0·5 mg/mL) combined with lidocaine and DEX is a safe and effective therapy for small superficial VMs of critical organs, such as the lips and the glans penis.Keywords
Funding Information
- National Natural Science Foundation of China (81171831)
This publication has 18 references indexed in Scilit:
- Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomasExperimental and Therapeutic Medicine, 2013
- Hemangiomas and Vascular Malformations: Current Theory and ManagementInternational Journal of Pediatrics, 2012
- Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: An evaluation of 297 consecutive patientsOral Oncology, 2009
- Neurointerventional Management of Low-Flow Vascular Malformations of the Head and NeckNeuroimaging Clinics Of North America, 2009
- Clinical Study of Sclerotherapy of Maxillofacial Venous Malformation Using Absolute Ethanol and PingyangmycinJournal of Oral and Maxillofacial Surgery, 2009
- Preliminary Study of Fibrin Glue Combined With Pingyangmycin for the Treatment of Venous Malformations in the Oral and Maxillofacial RegionJournal of Oral and Maxillofacial Surgery, 2008
- Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuateInternational Journal of Oral and Maxillofacial Surgery, 2004
- Intraarterial Lidocaine Administration for Relief of Pain Resulting from Transarterial Chemoembolization of Hepatocellular Carcinoma: Its Effectiveness and Optimal Timing of AdministrationCardioVascular and Interventional Radiology, 2001
- Sclerotherapy of Craniofacial Venous Malformations: Complications and ResultsPlastic and Reconstructive Surgery, 1999
- Hemangiomas and Vascular Malformations in Infants and ChildrenPlastic and Reconstructive Surgery, 1982